G. Bruno

发表

Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study.

M. Milella, L. Scudeller, C. Fabrizio, 2017, International journal of antimicrobial agents.

Influence of HLA‐B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals

G. Angarano, A. Saracino, L. Monno, 2019, Journal of medical virology.

Correction: Limiting Severe Outcomes and Impact on Intensive Care Units of Moderate-Intermediate 2009 Pandemic Influenza: Role of Infectious Diseases Units

S. Carbonara, G. Angarano, L. Monno, 2012, PLoS ONE.

X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the “inflamm-aging” process

L. Scudeller, G. Angarano, A. Saracino, 2013, BMC Infectious Diseases.

Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR.

N. Bartolomeo, M. Fasano, G. Angarano, 2015, The new microbiologica.

Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients

S. Lo Caputo, T. Santantonio, S. Carbonara, 2020, Journal of Gerontology and Geriatrics.

Letter: chronic hepatitis C genotype 3 infection – still a hurdle toward a direct‐acting anti‐viral‐induced HCV cure?

M. Milella, G. Angarano, A. Saracino, 2017, Alimentary pharmacology & therapeutics.

HCV-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?

M. Milella, L. Scudeller, C. Fabrizio, 2017 .

Limiting Severe Outcomes and Impact on Intensive Care Units of Moderate-Intermediate 2009 Pandemic Influenza: Role of Infectious Diseases Units

S. Carbonara, G. Angarano, L. Monno, 2012, PloS one.

Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients.

G. Angarano, A. Saracino, P. Maggi, 2017, In vivo.

Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio.

L. Scudeller, G. Angarano, A. Saracino, 2014, AIDS research and human retroviruses.

Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?

L. Scudeller, G. Angarano, A. Saracino, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Early Access to Oral Antivirals in High-Risk Outpatients: Good Weapons to Fight COVID-19

N. Bartolomeo, G. Buccoliero, G. Bruno, 2022, Viruses.

Calcium daily intake and the efficacy of a training intervention on optimizing calcium supplementation therapy: A clinical audit.

S. Ippolito, M. Maddaloni, V. Ruocco, 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome

C. Fabrizio, G. Buccoliero, G. Bruno, 2022, Infection.

COVID-19-associated pulmonary aspergillosis: adding insult to injury

C. Fabrizio, G. Buccoliero, G. Bruno, 2020, The Lancet Microbe.

The Revival of an "Old" Marker: CD4/CD8 Ratio.

G. Angarano, A. Saracino, L. Monno, 2017, AIDS reviews.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?

M. Milella, L. Scudeller, C. Fabrizio, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

The elderly and direct antiviral agents: Constraint or challenge?

M. Milella, S. Lo Caputo, L. Scudeller, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation

R. Maserati, P. Vitiello, F. Adorni, 2020, HIV research & clinical practice.

HCV and diabetes: towards a 'sustained' glycaemic improvement after treatment with DAAs?

L. Scudeller, C. Fabrizio, G. Angarano, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Pancreatic injury in the course of coronavirus disease 2019: A not‐so‐rare occurrence

C. Fabrizio, C. Santoro, G. Buccoliero, 2020, Journal of medical virology.

Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an infectious diseases unit in Southern Italy

C. Fabrizio, G. Buccoliero, G. Bruno, 2020, Journal of Infection.

Oral antivirals against Sars-CoV-2 in multiple myeloma outpatients: a case series.

G. Buccoliero, G. Palazzo, G. Bruno, 2023, Recenti progressi in medicina.

Monkeypox in the elderly: Is an unwelcome surprise to be expected?

G. Buccoliero, G. Bruno, 2022, Maturitas.

HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.

A. Andriulli, G. Lauletta, M. Milella, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Monkeypox in a 71‐year‐old woman

C. Fabrizio, G. Buccoliero, G. Bruno, 2022, Journal of Medical Virology.

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients

A. d’Arminio Monforte, M. Capobianchi, M. Shanyinde, 2018, PloS one.

Sofosbuvir‐based regimens against an “easy” villain: HCV genotype 2

M. Milella, G. Angarano, A. Saracino, 2017, Liver international : official journal of the International Association for the Study of the Liver.

The elderly and direct antiviral agents: Constraint or challenge?

M. Milella, S. Lo Caputo, L. Scudeller, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.